Maternal serum free-β-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13+6 weeks in relation to co-variables in pregnant Saudi women

被引:18
作者
Ardawi, Mohammed-Salleh M.
Nasrat, Hasan A.
Rouzi, Abdulrahim A.
Qari, Mohammed H.
Al-Qahtani, Mohammed H.
Abuzenadah, Adel M.
机构
[1] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21465, Saudi Arabia
[2] King Abdulaziz Univ Hosp, Jeddah 21465, Saudi Arabia
[3] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Technol, Jeddah 21465, Saudi Arabia
[4] King Abdulaziz Univ, Genom Med Unit, Jeddah 21465, Saudi Arabia
关键词
first trimester; fetal nuchal translucency; maternal serum screening; co-variables;
D O I
10.1002/pd.1661
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective To establish normative values and distribution parameters of first-trimester screening markers, namely, fetal nuchal translucency (NT), maternal serum free beta-human chorionic gonadotrophin (beta-hCG) and pregnancy-associated plasma protein-A (PAPP-A), at 10 to 13(+6) weeks of gestation in Saudi women and to evaluate the effect of co-variables including maternal body weight, gravidity, parity, fetal gender, twin pregnancy, smoking and ethnicity on these markers. Methods A cohort of Saudi women (first cohort n = 1616) with singleton pregnancies prospectively participated in the present study, and fetal NT together with maternal serum free beta-hCG and PAPP-A were determined at 10 to 13(+6) weeks of gestation. The distribution of gestational age-independent multiples of the median (MoM) of the parameters was defined and normative values were established, and correction for maternal body weight was made accordingly. The influence of various co-variables was examined using the data collected from the first and the second (n = 1849) cohorts of women and 62 twin pregnancies, and compared with other studies. Results All markers exhibited log-normally distributed MoMs. Gestational age-independent normative values were established. Maternal body weight was corrected, particularly for maternal free beta-hCG and PAPP-A using standard methods. Fetal NT showed a negative relationship with increasing gravidity (r = -0.296) or parity (r = -0.311), whereas both free beta-hCG and PAPP-A exhibited a significant positive relationship. There was a significant increase in the MoM of free beta-hCG in female fetuses. Smoking decreased MoM values of free beta-hCG (by 14.6%; P < 0.01) and PAPP-A (by 18.8%; P < 0.001). Twin pregnancy showed significant increases in MoM values of free beta-hCG (by 1.87-fold) and PAPP-A (by 2.24-fold), with no significant changes in fetal NT MoM values. Fetal NT MoM values were lower in Africans and Asians but higher in Orientals, as compared to Saudi women (P < 0.05; in each case). MoM values (body weight-corrected) of free beta-hCG were 25.2% higher in Africans and 19.4% higher in Orientals but 6.8% lower in other Arabian and Asian (by 5.8%) women as compared to Saudi women (P < 0.05; in each case). Conclusions The normative values and distribution parameters for fetal NT, maternal serum free beta-hCG and PAPP-A were established in Saudi singleton pregnancies, the maternal body weight together with smoking, twin pregnancy and ethnicity being important first-trimester screening co-variables. Gravidity, parity and fetal gender are also considered to influence one or more of the first-trimester markers examined. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 84 条
[1]   One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15 030 pregnancies [J].
Bindra, R ;
Heath, V ;
Liao, A ;
Spencer, K ;
Nicolaides, KH .
ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2002, 20 (03) :219-225
[2]   The effect of ethnic origin on nuchal translucency at 10-14 weeks of gestation [J].
Chen, M ;
Lam, YH ;
Tang, MHY ;
Lee, CP ;
Sin, SY ;
Tang, R ;
Wong, HS ;
Wong, SF .
PRENATAL DIAGNOSIS, 2002, 22 (07) :576-578
[3]   Precision of risk in multidimensional likelihood ratio based screening with first trimester screening for Down's syndrome as a special case [J].
Christiansen, M ;
Larsen, SO .
JOURNAL OF MEDICAL SCREENING, 2001, 8 (02) :61-64
[4]   Combined ultrasound and biochemical screening for Down's Syndrome in the first trimester: a Scottish multicentre study [J].
Crossley, JA ;
Aitken, DA ;
Cameron, AD ;
McBride, E ;
Connor, JM .
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2002, 109 (06) :667-676
[5]  
De Biasio P, 1999, PRENATAL DIAG, V19, P360, DOI 10.1002/(SICI)1097-0223(199904)19:4<360::AID-PD556>3.0.CO
[6]  
2-U
[7]  
de Graaf IM, 2000, PRENATAL DIAG, V20, P186, DOI 10.1002/(SICI)1097-0223(200003)20:3<186::AID-PD776>3.0.CO
[8]  
2-A
[9]   STRUCTURAL-CHANGES IN PLACENTAL BARRIER OF SMOKING MOTHER - A QUANTITATIVE AND ULTRASTRUCTURAL-STUDY [J].
DEMIR, R ;
DEMIR, AY ;
YINANC, M .
PATHOLOGY RESEARCH AND PRACTICE, 1994, 190 (07) :656-667
[10]   First-trimester screening: An overview [J].
Eiben, B ;
Glaubitz, R .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2005, 53 (03) :281-283